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The TRPM4 inhibitor 9-phenanthrol activates endothelial cell IKCa channels in rat 
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Background and purpose 
 
Smooth muscle TRPM4 channels play a fundamental role in the development of the 
myogenic arterial constriction that is necessary for blood flow autoregulation. As 
TRPM4 channels are present throughout the vasculature, we investigated their 
potential role in non-myogenic resistance arteries using the TRPM4 inhibitor 9-
phenanthrol. 
 
Experimental Approach 
Pressure and wire myography were used to assess artery reactivity, the latter in 
combination with measurements of smooth muscle membrane potential. 
Immunohistochemistry and endothelial cell (EC) calcium changes were assessed in 
pressurized vessels and patch clamp measurements made in isolated ECs. 
 
Key Results 
The TRPM4 inhibitor, 9-phenanthrol reversibly hyperpolarized mesenteric arteries to 
circa EK and blocked α1-adrenoceptor mediated vasoconstriction. Hyperpolarization 
was abolished and vasoconstriction reestablished by damaging the endothelium.  In 
mesenteric and cerebral artery smooth muscle, 9-phenanthrol hyperpolarization was 
effectively blocked by the IKCa inhibitor TRAM-34. 9-Phenanthrol did not increase 
mesenteric EC [Ca2+]i, and Na+ substitution with N-Methyl-D-glucamine (NMDG) 
only increased the muscle resting potential by 10 mV. Immunolabelling for TRPM4 
was restricted to the endothelium and perivascular tissue. 
 
Conclusions and Implications 
These data reveal a previously unrecognized action of the TRPM4 inhibitor 9-
phenanthrol, the ability to activate EC IKCa channels. They do not indicate a 
functionally important role for TRPM4 channels in the reactivity of non-myogenic 
mesenteric arteries.  
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Introduction 
 
Transient receptor potential melastatin 4 (TRPM4) channels are calcium-activated, 
non-selective cation channels. The channels are impermeable to Ca2+ ions and have 
been suggested to play a fundamental role in cerebrovascular myogenic contraction. 
By conducting sodium, they are suggested to cause smooth muscle cell (SMC) 
depolarization, which opens voltage-gated calcium channels allowing Ca2+ influx that 
then generates myogenic contraction (Earley et al., 2007; Earley et al., 2004). 
Evidence to support this suggestion was initially based on the use of TRPM4 
antisense oligodeoxynucleotides, which suppressed both pressure-induced 
depolarization and myogenic constriction in cerebral arteries (Earley et al., 2004). 
These observations were significantly extended by the use of the TRPM4 blocker, 9-
phenanthrol (9-hydroxyphenanthrene). As well as blocking TRPM4 currents in 
dispersed SMCs, in cerebral arteries 9-phenanthrol reversibly hyperpolarized the 
vascular SMCs to circa -70 mV. This effect was correlated with a reduction in 
myogenic tone of around 75% (Gonzales et al., 2010).  
 
9-Phenanthrol was first identified as a selective TRPM4 blocker by screening 
different hydroxytricyclic compounds in HEK-293 cells expressing either TRPM4 or 
the closely related cation channel TRPM5 (Grand et al., 2008). 9-Phenanthrol was 
subsequently shown to block TRPM4 channels with similar potency in native cells 
from a range of different tissues (Guinamard et al., 2014). For example, in isolated 
cerebrovascular SMCs, 9-phenanthrol inhibited TRPM4 currents with an IC50 in the 
low micromolar range, but did not affect the activity of a number of other types of ion 
channel (Gonzales et al., 2010).  
 
TRPM4 channels are widely expressed across a range of different tissues and, based 
on indirect studies, thought to be present in small mesenteric arteries (Weston et al., 
2013). In view of the proposed role of TRPM4 channels in myogenic contraction, we 
used the selective blocker 9-phenanthrol to investigate the potential role of these 
channels in mesenteric resistance arteries of a size that does not generate myogenic 
contraction. Although overall our data were similar to the reported effect of this agent 
in cerebral arteries, 9-phenanthrol appeared to evoke hyperpolarization by activating 
calcium activated K+ channels (KCa) in the endothelium. In addition, these data do not 
indicate a functional role for TRPM4 channels in mesenteric resistance artery 
reactivity, but further emphasize the importance of IKCa channels in regulating 
membrane potential and vascular tone. 
 
Methods 
 
Preparation of arteries for pressure or wire myography 
Animal use complied with the University of Oxford local ethical guidelines and the 
Animals (Scientific Procedures) Act 1986. Male Wistar rats (225-250g) were killed 
by cervical dislocation and exsanguination (as specified by Schedule 1 of the Animals 
(Scientific Procedures) Act 1986, UK). The mesenteric arcade was removed and 
placed in ice-cold MOPS buffer containing (mM): 145 NaCl, 4.7 KCl, 2 CaCl2, 1.17 
MgSO4·7H2O, 2 MOPS, 1.2 NaH2PO4·H2O, 5 glucose, 2 pyruvate, 0.02 EDTA, 2.75 
NaOH with pH adjusted to 7.40 ± 0.02 (at 37ºC) with NaOH. A third-order segment 
of mesenteric artery (external diameter between 250-350 µm at 70 mmHg) with no 
visible side branches was dissected free of adherent tissue. After the artery was 
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mounted in either a pressure or wire myograph, reactivity was assessed by 
preconstriction with phenylephrine (PE, 0.5 - 3 µM) followed by endothelium-
dependent relaxation to acetylcholine (ACh, 0.1 and 1 µM). Only vessels that relaxed 
by more than 95% were used further. 
 
Measurement of smooth muscle membrane potential 
Segments of mesenteric artery (2 mm) were mounted in a Mulvany-Halpern wire 
myograph (model 400A, Danish Myo Technology, Denmark) in Krebs solution 
containing (mM): 118 NaCl, 25 NaHCO3, 3.6 KCl, 1.2 MgSO4·7H2O, 1.2 KH2PO4, 
2.5 CaCl2, 11 glucose and gassed with 21% O2, 5% CO2, balance N2 at 37ºC. The 
temperature was increased to 37ºC, and arteries normalized to a resting tension 
equivalent to that generated at 90% of the diameter of the vessel at 70 mmHg. Artery 
viability was then assessed as described above.  
 
The SMC membrane potential was measured using sharp glass microelectrodes 
backfilled with 2 M KCl (tip resistances circa 100 MΩ), as previously described 
(Garland & McPherson, 1992; Garland et al., 2011b). Membrane potential was 
recorded through a pre-amplifier (Neurolog system, Digitimer Ltd., U.K.) linked to a 
MacLab data acquisition system (AD Instruments Model 4e, usually at 100 Hz). All 
drugs were added directly to the bath or, in the case of NMDG, substituted for [Na+]o 
in the Krebs solution. 
 
Measurement of endothelial cell membrane potential 
For patch clamp studies, ECs were isolated from mesenteric arteries that had been cut 
open and placed in nominally Ca2+-free physiological saline solution (HEPES-PSS) 
containing (mM): 130 NaCl, 5 KCl, 1.2 MgCl2, 10 glucose, 10 HEPES (pH adjusted 
to 7.40 ± 0.02 with NaOH) with the additional presence of 1 mg/ml papain, 1 mg/ml 
bovine serum albumin (BSA, fraction V) and 1 mg/ml dithiothreitol for 10 min at 
room temperature and then for 30 min at 36ºC. The arteries were then washed in Ca2+-
free BSA-containing HEPES-PSS and gently triturated to release ECs. Cell 
suspensions were stored on ice (the Ca2+ concentration was gradually increased to 0.5 
mM) and used on the same day. All patch clamp recordings were performed in 
HEPES-PSS containing 1 mM CaCl2. The recording pipette solution contained (mM): 
140 KCl, 2 MgATP, 0.1 Na2GTP, 0.5 MgCl2, 10 HEPES, 0.1 EGTA, pH adjusted to 
7.20 with KOH. 
 
Membrane potential was recorded from EC sheets (containing between 3 and >20 
cells, mean 13 ± 2, n=25) using the current clamp mode of the whole-cell patch clamp 
technique at sampling rate 10 Hz (Axoclamp 200B amplifier; Axon Instruments, 
Union City, CA, USA). Pipette resistance, when filled with pipette solution, was 5-10 
MΩ.  
 
 
Measurement of endothelial [Ca2+]i changes 
Arteries were cannulated with two glass micropipettes in a temperature-regulated 
chamber (2 mL, Warner Instruments) placed on the stage of an inverted microscope 
(FluoView500 linescan confocal, Olympus, Japan) as previously described (Kansui et 
al., 2008). Following equilibration and testing arterial function the ECs were 
selectively loaded with Ca2+ indicator dye. Briefly, the intraluminal pressure was 
lowered to 4 mmHg and the artery perfused with MOPS buffer containing 0.02% 
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Pluronic F-127 and the cell-permeable Ca2+ dye Oregon Green 488 BAPTA-1 AM 
(OGB-1, 10 µM, 30 min) (Kansui et al., 2008). After the dye was washed out of the 
lumen with MOPS buffer, the pressure was increased and the artery left for another 30 
min to allow de-esterification. Arteries were then excited at 488 nm and emitted light 
collected at >505 nm with a 40x water immersion objective (UApo N340, Olympus, 
Japan). ECs were visualized in a clip box of 472x144 pixels allowing a scan 
frequency of ~3 Hz. Cells (6-10 cells) were selected and fluorescence intensity was 
determined off-line using MetaMorph software (v.7.7.4, Molecular Devices, USA). 
Subcellular regions of interest (diameter ~ 2 µm) were manually positioned within 
each EC, and the Ca2+ events counted to obtain a frequency of events per cell per 
minute. Only active cells were included in the average. Results are also presented for 
the % active cells. All agents were added to the bath. 
 
Immunohistochemistry 
Immunohistochemistry was performed in pressurized arterioles as described 
previously (Bagher et al., 2012; Dora et al., 2008). In brief, arterioles were fixed in 
2% (wt/vol) paraformaldehyde for 10 min at 37°C, washed with PBS, and incubated 
in blocking buffer (luminal and abluminal, 1% BSA and 0.1% Tween 20, pH 7.1) for 
60 min at 37°C, then overnight with primary antibody at 4°C. Primary antibodies 
were as follows: 1:200 rabbit polyclonal anti-rat TRPM4 (aa 1110–1160; Abcam, 
ab63080); 1:100 rabbit polyclonal anti-mouse connexin 40 (aa 340–358; Chemicon 
International, AB1726). The following day, the bath solution was replaced with PBS, 
and the lumen was perfused with Alexa Fluor 488 secondary antibody (1:100 chicken 
anti-rabbit IgG, Life Technologies, A-21441; or for connexin 40, 1:100 goat anti-
rabbit IgG, Life Technologies, A-11034), and incubated for 2 h at room temperature. 
When double immunolabelling was performed, a 3 day protocol was used whereby 
the artery was imaged for TRPM4 expression prior to incubation with the Cx40 Ab 
and secondary Ab. Nuclei and elastin (including the IEL) were labelled with 15 µM 
propidium iodide and 200 nM Alexa Fluor 633 hydrazide (Life Technologies, A-
30634), respectively. Arteries were excited at 488, 543, and 633 nm; the fluorescence 
emitted at 505–540 (GaAsP detector), 560–620, and 655–755nm was acquired 
through a water immersion objective (40x, NA 1.15; Olympus, 1,024 x 1,024 pixels, 
sequential scanning) by using an Olympus FluoView1200 microscope (Olympus, 
Japan). z-Stacks through the artery wall were obtained at 0.5 µm increments with 
Fluoview Software (FV10-ASW 4.1; Olympus) and reconstructed in Imaris Software 
(Version 7.7.1; Bitplane). 
 
Measurement of cerebral artery diameter 
Middle cerebral arteries were cannulated with two glass pipettes in a temperature-
regulated chamber (10 mL, MOPS buffer, 120CP, Danish Myo Technology, 
Denmark) placed on the stage of an inverted microscope (IX71, Olympus, Japan) as 
previously described (Yuill et al., 2011). The preparations were then warmed to 37°C, 
and pressure, driven by custom-built gravity-fed inflow and outflow system, was 
gradually increased to 80 mmHg. Arteries were visualized using a 10x/0.25 Olympus 
objective and video camera (C7500-51, Hamamatsu Inc, Japan) and vessel diameter 
changes tracked at 2 Hz using Diamtrak Edge-tracking software (v3.5, Diamtrak, 
Adelaide, Australia). All experiments were performed in the absence of intraluminal 
flow. Arteries developed spontaneous myogenic tone within ~30 min, and EC-
function tested as dilation to ~95% of maximum diameter following addition of 
SLIGRL (protease-activated receptor 2 ligand, 10 µM) or ADPβS (3 µM).  
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Data analysis  
Data were analyzed using Microsoft Excel 2011 (Microsoft Corporation) and 
GraphPad Prism (v5.0, GraphPad Software, USA) software. Dilation was expressed 
as a percentage reversal of tone induced by PE (100% corresponding to the maximal 
diameter). Results are summarized as mean ± S.E.M. of n replicates, where n is the 
number of individual arteries, each obtained from a separate animal. Statistical 
analyses were performed using Student's paired t-test or one-way ANOVA analysis 
followed by Bonferroni post-test.  A value of P < 0.05 was considered to be 
statistically significant.  
 
Drugs and solutions 
All drugs were obtained from Sigma (UK) with the exception of apamin (Latoxan, 
France), levcromakalim (Tocris, UK) and OGB-1 (Life Technologies, UK). TRAM-
34 (1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole), 9-phenanthrol (9-
hydroxyphenanthrene) and glibenclamide were dissolved in dimethyl sulfoxide, 
levcromakalim in ethanol. All other stock solutions were prepared using purified 
(MilliQ) water. All stock solutions were prepared at 10-2 M, except for L-NAME (10-1 
M), and subsequently diluted in MOPS buffer (pressurized arteries) or Krebs buffer 
(wire myograph). Inhibitors were pre-incubated with the arterial tissue for at least 20 
min before agonist application. 
 
Results 
 
Smooth muscle hyperpolarization to the TRPM4 blocking agent 9-phenanthrol and 
the influence of K channel blockers 
9-Phenanthrol (20 µM) was previously shown to block TRPM4 current in native 
cerebral artery SMCs (Gonzales et al., 2010) and in intact mesenteric arteries it 
stimulated a robust SMC hyperpolarization, which was both reversible and 
reproducible (Figure 1A, i-ii). The hyperpolarization to 9-phenanthrol was 
concentration-dependent, ranging from 1.9 ± 0.6 mV with 5 µM (n=5) to a maximum 
of 26.5 ± 1.2 mV (n=10) with 20 µM 9-phenanthrol (from a resting potential of  -54.4 
± 1.2 mV). 
 
Hyperpolarization to 20 µM 9-phenanthrol was effectively abolished by the IKCa 
inhibitor, 1 µM TRAM-34, which reduced the hyperpolarization to 4.1 ± 1.5 mV 
(n=4) (Figure 1C). The effect was similar in the additional presence of the SKCa 
blocker, 100 nM apamin (2.5 ± 1.0 mV, n=7), while alone apamin did not reduce 
hyperpolarization to 9-phenanthrol (28.7 ± 3.0 mV, n=4) (Figure 1C). In the 
continued presence of TRAM-34, apamin and 9-phenanthrol, the opener of KATP 
channels 5 µM levcromakalim was still able to hyperpolarize to near EK (from -59.0 ± 
2.6 to -82.4 ± 4.4 mV, n=5). Some attenuation of hyperpolarization to 9-phenanthrol 
was recorded in the presence of the KATP blocker, 5 µM glibenclamide (to 20.1 ± 1.4 
mV, P < 0.05, n=5) (Figure 1B).  
 
The possibility 9-phenanthrol might cause hyperpolarization by block of a 
depolarizing Na+ conductance was probed by replacing [Na+]o with NMDG. This 
increased SMC resting membrane potential by around 10 mV, to -63.7 ± 1.5 mV, P < 
0.05, n=10 (Figure 1D). 
 7 
The effect of 9-phenanthrol against smooth muscle membrane potential and 
vasoconstriction in endothelium damaged mesenteric arteries 
In mesenteric arteries in which the endothelium had been damaged with a human hair 
(-EC), neither ACh (0.1 - 3 µM, n=3) nor 9-phenanthrol (20 µM, n=5) changed the 
SMC resting membrane potential (of -47.9 ± 2.5 mV, n=5), but robust 
hyperpolarization was still evoked by the subsequent addition of 5 µM levcromakalim 
(to around EK, Figure 2A). During hyperpolarization to 20 µM 9-phenanthrol in +EC 
arteries, both the depolarization and contraction normally evoked by the α1-
 
 
 
 
 
Effect of 9-phenanthrol on the smooth muscle membrane potential of mesenteric 
arteries and block with TRAM-34. Panel A, (i-ii) intracellular records showing 
reproducible and reversible hyperpolarization to 20 µM 9-phenanthol (9-PA) in the 
same preparation (iii) which, in a separate preparation, was unaffected by the 
presence of 100 nM apamin, (iv) but blocked in the additional presence of 1 µM 
TRAM-34. Under these conditions, hyperpolarization was subsequently evoked with 
5 µM levcromakalim (LVK). Panel B-D, box and whisker plots summarizing (B) the 
effect of 20 µM 9-phenanthrol against resting membrane potential (RMP, left panel, 
n=10) and in the presence of 5 µM glibenclamide (Glib, n=5), (C) lack of block with 
100 nM apamin alone and block with 1 µM TRAM-34 alone (n=4 in each case), (D) 
the effect of [Na+]o replacement with NMDG on the resting membrane potential 
(n=10). *, P < 0.05 vs RMP; #, P < 0.05 vs Control 9-PA. 
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adrenoceptor agonist phenylephrine was blocked (Figure 2B). Phenylephrine 
contractile responses in the presence of 9-phenanthrol were restored in -EC arteries 
(Figure 2B). 
 
 
Endothelial cell calcium events 
ECs in situ in pressurized mesenteric arteries displayed spontaneous Ca2+ events at a 
frequency of 2.1 ± 0.5 per active cell per min in 34 ± 1.0% of cells (n=3). This 
increased to 14.6 ± 3.1 per active cell per min in 86.2 ± 7.8% of cells during 
 
 
Damage to the endothelium (-EC) abolished hyperpolarization to acetylcholine and 9-
phenanthrol but not to levcromakalim.  Panel A, intracellular recording showing no 
hyperpolarization to 0.1 – 3 µM acetylcholine (ACh) or 20 µM 9-phenanthrol (9-PA), 
while the addition of the KATP channel activator, 5 µM levcromakalim (LVK) evoked 
pronounced hyperpolarization to circa EK. Panel B, concentration-response curves 
showing control contraction to phenylephrine (PE) is abolished in the presence of 20 
µM 9-phenanthrol but reestablished in endothelium-damaged arteries in the presence 
of 9-phenanthrol (n=3 in each case). *, P < 0.05 vs Control. 
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stimulation with 0.3 µM ACh (n=3). 9-Phenanthrol reversibly blocked the EC Ca2+ 
response to ACh but did not alter spontaneous basal Ca2+ activity (Figure 3). 
 
 
Hyperpolarization to 9-phenanthrol in isolated endothelial cell sheets 
Under conditions of current clamp, isolated EC sheets had a resting membrane 
potential of -10.9 ± 1.4 mV, n=25. Application of a sub-maximal concentration of 9-
phenanthrol (5 µM) reversibly hyperpolarized EC sheets (to circa EK, -75.6 ± mV, 
n=4) (Figure 4). TRAM-34 (1 µM) reduced this hyperpolarization by 44% (to -32.6 ± 
 
Measurement of endothelial cell calcium events and active cells in pressurized 
mesenteric arteries. 20 µM 9-phenanthrol (9-PA) did not alter basal Ca2+ event 
frequency or the number of active cells, but blocked the ability of 0.3 µM ACh to 
stimulate events (n=3). *, P < 0.05 vs Basal. 
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5.2 mV, P < 0.05, n=4) (Figure 4B). The low EC resting potential appeared to be due 
to a [Na+]o conductance, as NMDG reversibly increased the EC resting membrane 
potential to -57.5 ± 4.7 mV, n=11 (Figure 4C). 
 
 
 
 
 
 
 
 
Current clamp recording from dispersed mesenteric artery EC sheets. Panel A, 
original trace showing reproducible and reversible hyperpolarization to 5 µM 9-
phenanthrol, reduced in the presence of 1 µM TRAM-34. Panel B, box and whisker 
plot of paired data summarizing hyperpolarization to 5 µM 9-phenanthrol and reduced 
hyperpolarization (right panel) in the presence of 1 µM TRAM-34 (n=4 EC sheets). 
Panel C, summary of the hyperpolarization to superfusate containing NMDG (n=11 
EC sheets). *, P < 0.05 vs RMP; #, P < 0.05 vs Control 9-PA. 
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Immunohistochemical profile for TRPM4 in mesenteric arteries 
 
No immunolabelling with TRPM4 antibody was observed in mesenteric artery SMCs. 
However, both endothelium and the perivascular plexus were labelled by the TRPM4 
antibody (Figure 5). 
 
 
 
 
Confocal imaging in pressurized mesenteric arteries indicating TRPM4 antibody in 
endothelium and adventitia. i. Transmitted light image showing the relative alignment 
of endothelial cells (EC) and smooth muscle cells (SMC). Nuclear labelling (blue) 
with propidium iodide. ii. A merged image from the same artery (of five 0.5-µm z-
axis planes) at the level of the internal elastic lamina (Elastin, white), focal plane EC 
in panel v. iii. Diffuse expression of TRPM4 (yellow) is apparent in the endothelium 
but absent from the SMCs. iv. Subsequent immunolabelling of the same artery for 
connexin 40 (yellow) using the same settings as iii, was restricted mainly to EC 
borders. v. Cartoon indicating the focal plane imaged for endothelial cells (EC) and 
shown in panels i-iv, and for adventitia shown in panel viii. vi. Reconstructed z-stacks, 
luminal surface upmost, showing alignment of SMCs approximately at right angles to 
the overlying ECs. vii. The same reconstructed z-stack including signal (yellow) 
indicating TRPM4 in the endothelium but absent from the SMC. viii. TRPM4 was 
also apparent at the level of the adventitia. Scale bar 50 µm applicable to all images. 
The pink asterisk marks the same nucleus in panels i-iv and vi-viii. 
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Effect of 9-phenanthrol in middle cerebral arteries 
 
Isolated middle cerebral arteries mounted under isometric conditions developed 
myogenic tone and depolarization superimposed by spontaneous spike potentials. 
Myogenic tone and spike potentials were inhibited by the application of 1 µM 
nifedipine. The subsequent application of 20 µM 9-phenanthrol increased the resting 
membrane potential (-42.1 ± 1.0 mV) by 17.2 ± 1.8 mV (n=4). The increase was 
reduced to 5.5 ± 1.2 mV in the presence of TRAM-34 (P < 0.05, n=4) (Figures 6A & 
B). In pressurized arteries, which developed myogenic tone (maximum inner diameter 
219 ± 4 µm, 44 ± 2% myogenic tone), 9-phenanthrol caused a rapid vasodilation and 
TRAM-34 markedly reduced the rate of vasodilation (Figure 6C). TRAM-34 did not 
markedly affect myogenic tone (50 ± 3%, n=3). 
 
 
 
 
 
 
 
Inhibition of 9-phenanthrol hyperpolarization and vasodilation in middle cerebral 
arteries by TRAM-34. Panel A, intracellular recording of smooth muscle membrane 
potential in a tensioned middle cerebral artery. Spontaneous depolarization and 
contraction is blocked with 1 µM nifedipine. 20 µM 9-phenanthrol then causes 
hyperpolarization. Panel B, box and whisker plot to summarize the ability of 20 µM 
9-phenanthrol to raise membrane potential (left panel), and (right) reduced in the 
presence of 1 µM TRAM-34, n=4. Panel C, vasodilation to 20 µM 9-phenanthrol in 
pressurized cerebral arteries is slowed but not diminished by the presence of 1 µM 
TRAM-34, n=3. *, P < 0.05 vs RMP. 
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Discussion 
 
There are three major outcomes from the present study. In spite of the accepted 
selectivity of 9-phenanthrol for TRPM4 channels, we provide evidence to show first 
that it can also activate IKCa channels, which in vascular tissue are focused within the 
endothelium; and second can block the acetylcholine-mediated increase in EC Ca2+; 
each of these effects being reversible. Third, taken together our data are not consistent 
with a functional role for TRPM4 channels in mesenteric artery reactivity, certainly in 
non-myogenically active arteries. 
 
9-Phenanthrol is the most selective TRP ligand currently available for TRPM4 
channels, and appears not to affect the closely related TRPM5 channel even in 
concentrations as high as 100 µM (Grand et al., 2008).  Since this characteristic was 
first described, 9-phenanthrol has also been shown to lack activity against a range of 
other ion channels (summarized in Guinamard et al., 2014). In myogenically active 
cerebral arteries, these include BKCa, Kv, Kir and voltage-dependent Ca2+ channels 
(Gonzales et al., 2010). Furthermore, while 9-phenanthrol abolished TRPM4 currents 
in cerebral SMCs, it had no effect against the currents mediated by either TRPC3 or 
TRPC6 channels (expressed in HEK-293 cells). The latter channels are present in 
cerebral SMCs and have been implicated in constrictor responses. In EC-intact 
cerebral arteries, 9-phenanthrol hyperpolarized the SMCs by circa 30 mV, increasing 
the membrane potential to values close to EK. Based on the specificity of 9-
phenanthrol described above, this effect was attributed to block of an ongoing SMC 
depolarization generated by TRPM4 channels.  
 
In the present study, 9-phenanthrol evoked SMC hyperpolarization of similar 
magnitude and potency as reported in the earlier experiments with isolated cerebral 
arteries. However, the hyperpolarization in mesenteric artery SMCs did not appear to 
reflect a block of TRPM4 currents, but rather the activation of endothelial IKCa 
channels, as it was abolished either by the specific IKCa channel blocker TRAM-34 or 
by damage to the endothelium. In contrast, hyperpolarization was unaffected by the 
presence of apamin, which selectively blocks SKCa channels, the second form of KCa 
channel in the endothelium. Activation of both IKCa and SKCa channels in the 
endothelium underpins endothelium-dependent hyperpolarization (EDH) in both rat 
mesenteric and middle cerebral arteries (McNeish et al., 2006). EDH is responsible 
for the nitric oxide independent vasodilation in small resistance arteries/arterioles, and 
is the predominant endothelium-dependent response leading to vasodilation in these 
small arteries (Garland et al., 2011a). 
 
Glibenclamide also suppressed hyperpolarization to 9-phenanthrol. Although the 
effect was modest, at circa 6 mV, it was significant. Functional TRPM4 channels, in 
contrast to TRPM5 channels, are glibenclamide-sensitive, and also subject to complex 
modulation by intracellular ATP (Demion et al., 2007; Nilius et al., 2005). How 
glibenclamide inhibits TRPM4 channels is not clear, but an obvious possibility is that 
it is acting on sulphonylurea receptors (SUR).  SUR1 has been suggested to associate 
with TRPM4, to form SUR1-TRPM4 channels that are up-regulated acutely following 
CNS trauma and underlie the subsequent necrotic cell death (Woo et al., 2013). 
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However, the ability of SUR-1 and TRPM4 to associate and form channels has been 
questioned (Sala-Rabanal et al., 2012), but this discrepancy might simply reflect 
differing experimental conditions, because inhibition of SUR1-TRPM4 channels by 
glibenclamide reduces both neuroinflammation and the cognitive deficits that follow 
subarachnoid haemorrhage (Tosun et al., 2013). The fact that SUR1-TRPM4 channels 
have not been reported to be constitutively expressed, and that we failed to detect 
significant immunohistochemical signal for TRPM4 in mesenteric SMCs, suggests 
that similar channels probably do not explain the attenuated hyperpolarization that we 
recorded with glibenclamide. However, 9-phenanthrol and related phenanthrene 
derivatives inhibit a number of protein kinases, so perhaps they somehow affect the 
ATP-binding site (Wang et al., 1994). 
 
How 9-phenanthrol activates EC IKCa channels is not clear. This effect is not the 
result of an increase in EC [Ca2+]i, because neither event frequency nor the number of 
active cells was altered by 9-phenathrol. In fact, 9-phenanthrol reversibly blocked the 
ability of ACh to increase EC [Ca2+]i, events, indicating it disrupts cellular calcium 
handling, at least in the endothelium. This suggestion is consistent with the 'recovery' 
of phenylephrine-evoked contraction observed after EC damage, and strengthens the 
conclusion that the effect of 9-phenanthrol in mesenteric arteries is restricted to the 
endothelium. As a fused heteroaromatic structure, 9-phenanthol is a flat, rigid 
molecule. It shares these characteristics with the positive modulators of KCa channels, 
which are based on the structure of EBIO (1-ethyl-2-benzimidazolinone), such as 
NS309 and the benzothiazole SKA-31. These molecules are either completely 
aromatic or contain single bonds that will allow rotation and enable the molecule to 
form a flat structure. KCa channel activators appear to bind within the channel C-
terminal region, close to the calmodulin binding site. In contrast, channel blockers 
such as the clotrimazole derivative TRAM-34 are larger and less likely to assume a 
flat structure. They bind in the outer vestibular region of IKCa (Wulff & Kohler, 2013).  
 
In the middle cerebral artery, hyperpolarization to 9-phenthantrol also appeared 
largely due to activation of IKCa. However, consistent with a functional role for 
TRPM4 in the cerebral arteries, block of IKCa did not inhibit cerebral artery dilation, 
but it did slow the rate at which dilation developed. A recent study, in which 9-
phenanthrol evoked cerebral artery dilation in endothelium-denuded vessels, is 
consistent with these observations (Cipolla et al., 2014). In the same study, 9-
phenanthrol also evoked SMC hyperpolarization, but these (separate) recordings 
appeared to be from endothelium-intact arteries. Cerebral artery hyperpolarization to 
9-phenanthrol was proposed to arise due to block of a depolarizing sodium current 
(Gonzales et al., 2010). However, while it seems clear that TRPM4 channels are 
important for cerebral myogenic tone, our data question this explanation. 
 
In contrast to cerebral arteries, data from non-myogenic mesenteric arteries do not 
support a functional role for TRPM4 channels, at least in terms of arterial reactivity. 
Crucially, the hyperpolarization evoked with 9-phenanthrol was endothelium-
dependent and appeared to reflect a direct activation of IKCa channels. These data 
were supported by an absence of TRPM4 immunolabelling in the SMC layers and 
patch clamp measurements in ECs, which also showed hyperpolarization with 9-
phenanthrol to be TRAM-34 sensitive. Also consistent are data from experiments in 
which [Na+]o was replaced with non-permeant NMDG. This only increased resting 
membrane potential by 10 mV and contrasted with a circa 30 mV increase to 9-
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phenanthrol. NMDG also hyperpolarized isolated ECs, and interestingly to close to 
the value of resting membrane potential recorded in intact arteries. The latter 
suggesting that the depolarized EC resting potential reflects a sodium-dependent 
process. Whether or not that involves EC TRPM4 channels is not clear, but whatever 
the mechanism, it does not seem to have any important influence on arterial reactivity. 
Previous research has shown that dissociated ECs are depolarized, and this is thought 
to reflect the fact that in situ the EC resting membrane potential is dominated by the 
more hyperpolarized SMC resting potential, reflecting heterocellular gap-junction 
coupling between the two cell types (Yamamoto & Suzuki, 2005). 
 
In summary, our data do not support a role for TRPM4 channels in the reactivity of 
non-myogenic mesenteric arteries. They do reveal previously unrecognized effects of 
9-phenanthol, the ability to activate EC IKCa channels and as a result generate arterial 
hyperpolarization and relaxation, and to block acetylcholine-mediated EC Ca2+ 
activity. These actions of 9-phenantrol should be considered whenever this agent is 
used as a probe for TRPM4 activity in intact arteries. 
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Figure Legends 
 
Figure 1.  
 
 
Effect of 9-phenanthrol on the smooth muscle membrane potential of mesenteric 
arteries and block with TRAM-34. Panel A, (i-ii) intracellular records showing 
reproducible and reversible hyperpolarization to 20 µM 9-phenanthol (9-PA) in the 
same preparation (iii) which, in a separate preparation, was unaffected by the 
presence of 100 nM apamin, (iv) but blocked in the additional presence of 1 µM 
TRAM-34. Under these conditions, hyperpolarization was subsequently evoked with 
5 µM levcromakalim (LVK). Panel B-D, box and whisker plots summarizing (B) the 
effect of 20 µM 9-phenanthrol against resting membrane potential (RMP, left panel, 
n=10) and in the presence of 5 µM glibenclamide (Glib, n=5), (C) lack of block with 
100 nM apamin alone and block with 1 µM TRAM-34 alone (n=4 in each case), (D) 
the effect of [Na+]o replacement with NMDG on the resting membrane potential 
(n=10). *, P < 0.05 vs RMP; #, P < 0.05 vs Control 9-PA. 
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Figure 2.  
 
Damage to the endothelium (-EC) abolished hyperpolarization to acetylcholine and 9-
phenanthrol but not to levcromakalim.  Panel A, intracellular recording showing no 
hyperpolarization to 0.1 – 3 µM acetylcholine (ACh) or 20 µM 9-phenanthrol (9-PA), 
while the addition of the KATP channel activator, 5 µM levcromakalim (LVK) evoked 
pronounced hyperpolarization to circa EK. Panel B, concentration-response curves 
showing control contraction to phenylephrine (PE) is abolished in the presence of 20 
µM 9-phenanthrol but reestablished in endothelium-damaged arteries in the presence 
of 9-phenanthrol (n=3 in each case). *, P < 0.05 vs Control. 
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Figure 3.  
 
Measurement of endothelial cell calcium events and active cells in pressurized 
mesenteric arteries. 20 µM 9-phenanthrol (9-PA) did not alter basal Ca2+ event 
frequency or the number of active cells, but blocked the ability of 0.3 µM ACh to 
stimulate events (n=3). *, P < 0.05 vs Basal. 
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Figure 4.  
 
Current clamp recording from dispersed mesenteric artery EC sheets. Panel A, 
original trace showing reproducible and reversible hyperpolarization to 5 µM 9-
phenanthrol, reduced in the presence of 1 µM TRAM-34. Panel B, box and whisker 
plot of paired data summarizing hyperpolarization to 5 µM 9-phenanthrol and reduced 
hyperpolarization (right panel) in the presence of 1 µM TRAM-34 (n=4 EC sheets). 
Panel C, summary of the hyperpolarization to superfusate containing NMDG (n=11 
EC sheets). *, P < 0.05 vs RMP; #, P < 0.05 vs Control 9-PA. 
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Figure 5.  
 
Confocal imaging in pressurized mesenteric arteries indicating TRPM4 antibody in 
endothelium and adventitia. i. Transmitted light image showing the relative alignment 
of endothelial cells (EC) and smooth muscle cells (SMC). Nuclear labelling (blue) 
with propidium iodide. ii. A merged image from the same artery (of five 0.5-µm z-
axis planes) at the level of the internal elastic lamina (Elastin, white), focal plane EC 
in panel v. iii. Diffuse expression of TRPM4 (yellow) is apparent in the endothelium 
but absent from the SMCs. iv. Subsequent immunolabelling of the same artery for 
connexin 40 (yellow) using the same settings as iii, was restricted mainly to EC 
borders. v. Cartoon indicating the focal plane imaged for endothelial cells (EC) and 
shown in panels i-iv, and for adventitia shown in panel viii. vi. Reconstructed z-stacks, 
luminal surface upmost, showing alignment of SMCs approximately at right angles to 
the overlying ECs. vii. The same reconstructed z-stack including signal (yellow) 
indicating TRPM4 in the endothelium but absent from the SMC. viii. TRPM4 was 
also apparent at the level of the adventitia. Scale bar 50 µm applicable to all images. 
The pink asterisk marks the same nucleus in panels i-iv and vi-viii. 
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Figure 6.  
 
Inhibition of 9-phenanthrol hyperpolarization and vasodilation in middle cerebral 
arteries by TRAM-34. Panel A, intracellular recording of smooth muscle membrane 
potential in a tensioned middle cerebral artery. Spontaneous depolarization and 
contraction is blocked with 1 µM nifedipine. 20 µM 9-phenanthrol then causes 
hyperpolarization. Panel B, box and whisker plot to summarize the ability of 20 µM 
9-phenanthrol to raise membrane potential (left panel), and (right) reduced in the 
presence of 1 µM TRAM-34, n=4. Panel C, vasodilation to 20 µM 9-phenanthrol in 
pressurized cerebral arteries is slowed but not diminished by the presence of 1 µM 
TRAM-34, n=3. *, P < 0.05 vs RMP. 
 
 
